Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$741,134
-$190,700 QoQ
Shares Held
30,778
-7.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1,503
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strategic Blueprint, LLC holds $25,782,970 across 8 Drug Manufacturers - General names. PFE ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,696 | $16,427,394 | |
| 2 | JNJ |
Johnson & Johnson
|
12,796 | $3,249,800 | |
| 3 | ABBV |
AbbVie Inc.
|
9,738 | $2,450,470 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,246 | $1,702,111 | |
| 5 | PFE |
Pfizer Inc
This page
|
30,778 | $741,134 | |
| 6 | AMGN |
Amgen Inc
|
1,477 | $534,851 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,819 | $356,152 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,572 | $321,058 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $741,134 | 30,778 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $931,834 | 33,185 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $829,493 | 33,313 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $936,109 | 36,739 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $941,239 | 38,830 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,140,274 | 44,999 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,251,393 | 47,169 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,337,809 | 46,227 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,465,844 | 52,389 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $1,406,203 | 50,674 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,030,941 | 35,809 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,504,757 | 45,365 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,625,730 | 44,322 | Shares | Sole | 2023-10-18 | |
| 2023-03-31 | $1,738,365 | 42,607 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $4,491,134 | 87,649 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,610,105 | 36,794 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,798,663 | 34,306 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,687,080 | 32,588 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $1,824,822 | 30,903 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,208,581 | 28,100 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,052,033 | 26,865 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $908,974 | 25,089 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $893,047 | 24,261 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $683,096 | 18,613 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $344,265 | 10,528 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $339,520 | 10,402 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||